首页 | 本学科首页   官方微博 | 高级检索  
检索        


Current use for old antibacterial agents: polymyxins, rifamycins, and aminoglycosides
Authors:Chen Luke F  Kaye Donald
Institution:a Division of Infectious Diseases and International Health, Department of Medicine, Duke University Medical Center, Box 102359, Hanes House, Durham, NC 27710, USA
b Department of Medicine, Drexel University College of Medicine, Philadelphia, PA 19102, USA
c 1535 Sweet Briar Road, Gladwyne, PA 19035, USA
Abstract:This article reviews three classes of antibacterial agents that are uncommonly used in bacterial infections and therefore can be thought of as special-use agents. The polymyxins are reserved for gram-negative bacilli that are resistant to virtually all other classes of drugs. Rifampin is used therapeutically, occasionally as a companion drug in treatment of refractory gram-positive coccal infections, especially those involving foreign bodies. Rifaximin is a new rifamycin that is a strict enteric antibiotic approved for treatment of traveler's diarrhea and is showing promise as a possible agent for refractory Clostridium difficile infections. The aminoglycosides are used mainly as companion drugs for the treatment of resistant gram-negative bacillary infections and for gram-positive coccal endocarditis.
Keywords:Rifaximin  Pharmacokinetics  Pharmacodynamics  Toxicity  Polymyxins  Aminoglycoside  Rifampin
本文献已被 ScienceDirect PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号